Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Blood Adv. 2024 Mar 26;8(6):1379-1383. doi: 10.1182/bloodadvances.2023011653.

Authors

Daniel Cancilla^{1

2}, Michael P Rettig¹, Darja Karpova¹, Haresh Thakellapalli³, Megh Singh^{1

2}, Marvin J Meyers^{2

3}, Peter G Ruminski^{1

2}, Stephanie Christ¹, Ezhilarasi Chendamarai¹, Feng Gao⁴, Leah Gehrs¹, Julie K Ritchey¹, Michael Prinsen², John F DiPersio¹

Affiliations

¹ Division of Oncology, Section of Stem Cell Biology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
² Saint Louis University School of Medicine, St. Louis, MO.
³ Department of Chemistry, Saint Louis University School of Science and Engineering, St. Louis, MO.
⁴ Division of Public Health Sciences, Washington University School of Medicine in St. Louis, St. Louis, MO.

No abstract available

MeSH terms

Hematopoietic Stem Cell Mobilization*
Hematopoietic Stem Cells / metabolism
Integrin alpha4beta1* / metabolism
Signal Transduction

Substances

Integrin alpha4beta1